Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 438070, 9 pages
http://dx.doi.org/10.1155/2014/438070
Research Article

Bronchoalveolar Lavage Fluid IFN- Th17 Cells and Regulatory T Cells in Pulmonary Sarcoidosis

1Department of Thoracic Medicine, St. Olavs University Hospital, Postboks 3250 Sluppen, 7006 Trondheim, Norway
2Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, 7006 Trondheim, Norway
3Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway
4Department of Laboratory Medicine, Children’s and Women’s Health, Norwegian University of Science and Technology, 7489 Trondheim, Norway
5Department of Circulation and Imaging, Norwegian University of Science and Technology, 7489 Trondheim, Norway

Received 26 January 2014; Accepted 9 April 2014; Published 5 May 2014

Academic Editor: Teresa Zelante

Copyright © 2014 Anders Tøndell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. S. Chen and D. R. Moller, “Sarcoidosis—scientific progress and clinical challenges,” Nature Reviews Rheumatology, vol. 7, no. 8, pp. 457–467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Prince, F. Kheradmand, and D. B. Corry, “16. Immunologic lung disease,” Journal of Allergy and Clinical Immunology, vol. 111, no. 2, supplement 2, pp. S613–S623, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Zissel, A. Prasse, and J. Muller-Quernheim, “Immunologic response of sarcoidosis,” Seminars in Respiratory and Critical Care Medicine, vol. 31, no. 4, pp. 390–403, 2010. View at Publisher · View at Google Scholar
  4. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Park, Z. Li, X. O. Yang et al., “A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17,” Nature Immunology, vol. 6, no. 11, pp. 1133–1141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Sakaguchi, M. Miyara, C. M. Costantino, and D. A. Hafler, “FOXP3+ regulatory T cells in the human immune system,” Nature Reviews Immunology, vol. 10, no. 7, pp. 490–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Miyara, G. Gorochov, M. Ehrenstein, L. Musset, S. Sakaguchi, and Z. Amoura, “Human FoxP3+ regulatory T cells in systemic autoimmune diseases,” Autoimmunity Reviews, vol. 10, no. 12, pp. 744–755, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. A. Long and J. H. Buckner, “CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game,” The Journal of Immunology, vol. 187, no. 5, pp. 2061–2066, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, no. 1, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Lee, A. Awasthi, N. Yosef et al., “Induction and molecular signature of pathogenic TH17 cells,” Nature Immunology, vol. 13, no. 10, pp. 991–999, 2012. View at Publisher · View at Google Scholar
  12. C. A. Piccirillo, “Regulatory T cells in health and disease,” Cytokine, vol. 43, no. 3, pp. 395–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Curtis and S. S. Way, “Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens,” Immunology, vol. 126, no. 2, pp. 177–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Facco, A. Cabrelle, A. Teramo et al., “Sarcoidosis is a Th1/Th17 multisystem disorder,” Thorax, vol. 66, no. 2, pp. 144–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. E. Zielinski, F. Mele, D. Aschenbrenner et al., “Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β,” Nature, vol. 484, no. 7395, pp. 514–518, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Bosniface, W. M. Blumenschein, K. Brovont-Porth et al., “Human Th17 cells comprise heterogeneous subsets including IFN-γ-producing cells with distinct properties from the Th1 lineage,” The Journal of Immunology, vol. 185, no. 1, pp. 679–687, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Kebir, I. Ifergan, J. I. Alvarez et al., “Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis,” Annals of Neurology, vol. 66, no. 3, pp. 390–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Duhen, S. Glatigny, C. A. Arbelaez, T. C. Blair, M. Oukka, and E. Bettelli, “Cutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-bet,” The Journal of Immunology, vol. 190, no. 9, pp. 4478–4482, 2013. View at Publisher · View at Google Scholar
  19. B. Richmond, K. Ploetze, J. Isom et al., “Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expression,” Journal of Clinical Immunology, vol. 33, no. 2, pp. 446–455, 2013. View at Publisher · View at Google Scholar
  20. M. Miyara, Z. Amoura, C. Parizot et al., “The immune paradox of sarcoidosis and regulatory T cells,” The Journal of Experimental Medicine, vol. 203, no. 2, pp. 359–370, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Rappl, S. Pabst, D. Riemann et al., “Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation,” Clinical Immunology, vol. 140, no. 1, pp. 71–83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Idali, J. Wahlström, C. Müller-Suur, A. Eklund, and J. Grunewald, “Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis,” Clinical & Experimental Immunology, vol. 152, no. 1, pp. 127–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. E. M. Eisenstein and C. B. Williams, “The T(reg)/Th17 cell balance: a new paradigm for autoimmunity,” Pediatric Research, vol. 65, no. 5, part 2, pp. 26r–31r, 2009. View at Publisher · View at Google Scholar
  24. K. Nistala and L. R. Wedderburn, “Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis,” Rheumatology, vol. 48, no. 6, pp. 602–606, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Afzali, G. Lombardi, R. I. Lechler, and G. M. Lord, “The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease,” Clinical and Experimental Immunology, vol. 148, no. 1, pp. 32–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Schmitt, L. Rink, and P. Uciechowski, “The Th17/Treg balance is disturbed during aging,” Experimental Gerontology, vol. 48, no. 12, pp. 1379–186, 2013. View at Publisher · View at Google Scholar
  27. C. T. Weaver, L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy, “Th17: an effector CD4 T cell lineage with regulatory T cell ties,” Immunity, vol. 24, no. 6, pp. 677–688, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. C. T. Weaver and R. D. Hatton, “Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective,” Nature Reviews Immunology, vol. 9, no. 12, pp. 883–889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. “Statement on sarcoidosis,” The American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 736–755, 1999.
  30. J. G. Scadding, “Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation,” British Medical Journal, vol. 2, no. 5261, pp. 1165–1172, 1961. View at Google Scholar
  31. A. Tøndell, A. D. Rø, A. Åsberg, M. Børset, T. Moen, and M. Sue-Chu, “Activated CD8+ T cells and NKT cells in BAL fluid improve diagnostic accuracy in sarcoidosis,” Lung, vol. 192, no. 1, pp. 133–140, 2014. View at Publisher · View at Google Scholar
  32. B. ten Berge, M. S. Paats, I. M. Bergen et al., “Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis,” Rheumatology, vol. 51, no. 1, pp. 37–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Wikén, J. Grunewald, A. Eklund, and J. Wahlström, “Multiparameter phenotyping of T-cell subsets in distinct subgroups of patients with pulmonary sarcoidosis,” Journal of Internal Medicine, vol. 271, no. 1, pp. 90–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Wikén, M. Ostadkarampour, A. Eklund et al., “Antigen-specific multifunctional T-cells in sarcoidosis patients with Löfgren’s syndrome,” European Respiratory Journal, vol. 40, no. 1, pp. 110–121, 2012. View at Publisher · View at Google Scholar
  35. M. Wikén, F. Idali, M. A. Al Hayja, J. Grunewald, A. Eklund, and J. Wahlström, “No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis,” Respiratory Research, vol. 11, article no. 121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Taflin, M. Miyara, D. Nochy et al., “FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions,” American Journal of Pathology, vol. 174, no. 2, pp. 497–508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Darlington, H. Haugom-Olsen, K. von Sivers et al., “T cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis—indication for an airborne antigen as the triggering factor in sarcoidosis,” Journal of Internal Medicine, vol. 272, no. 5, pp. 465–471, 2012. View at Publisher · View at Google Scholar
  38. J. O'Shea and W. E. Paul, “Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells,” Science, vol. 327, no. 5969, pp. 1098–1102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. H. Lexberg, A. Taubner, I. Albrecht et al., “IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells,” European journal of immunology, vol. 40, no. 11, pp. 3017–3027, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Annunziato, L. Cosmi, V. Santarlasci et al., “Phenotypic and functional features of human Th17 cells,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849–1861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Komatsu, K. Okamoto, S. Sawa et al., “Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis,” Nature Medicine, vol. 20, no. 1, pp. 62–68, 2014. View at Publisher · View at Google Scholar
  42. H. Huang, Z. Lu, C. Jiang, J. Liu, Y. Wang, and Z. Xu, “Imbalance between Th17 and regulatory T-Cells in sarcoidosis,” International Journal of Molecular Sciences, vol. 14, no. 11, pp. 21463–21473, 2013. View at Publisher · View at Google Scholar